These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12135145)

  • 41. [Relationship between reduced myocardial uptake of beta-methyl-p-(123I)- iodophenyl-pentadecanoic acid (123I-BMIPP) and regional diastolic ventricular dysfunction in patients with hypertrophic cardiomyopathy].
    Morozumi T; Ishida Y; Hori M; Kamada T; Yamagami H; Kozuka T; Kusuoka H; Nishimura T
    Kaku Igaku; 1993 Sep; 30(9):1037-47. PubMed ID: 8230824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systolic Flow Reversal in a Case of Mid-Ventricular Obstructive Hypertrophic Cardiomyopathy.
    Misumi I; Honda T; Kurokawa H; Kubota Y; Ishii M; Sato R; Yamabe H; Yasuda H; Kaikita K; Hokimoto S; Ogawa H
    Intern Med; 2015; 54(14):1765-9. PubMed ID: 26179533
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disopyramide improves the balance between myocardial oxygen supply and demand in patients with hypertrophic obstructive cardiomyopathy.
    Niki K; Sugawara M; Asano R; Oka T; Kondoh Y; Tanino S; Iwade K; Magosaki N; Kasanuki H; Hosoda S
    Heart Vessels; 1997; 12(3):111-8. PubMed ID: 9496461
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Provokable left ventricular outflow tract obstruction in a patient without hypertrophy.
    Pasquale F; Tomé-Esteban MT; Morgagni R; Elliott P
    Nat Rev Cardiol; 2009 Apr; 6(4):313-6. PubMed ID: 19352335
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Right ventricular involvement in hypertrophic cardiomyopathy. A case report and brief review of the literature].
    Comella A; Magnacca M; Gistri R; Lombardi M; Neglia D; Poddighe R; Pesola A
    Ital Heart J Suppl; 2004 Feb; 5(2):154-9. PubMed ID: 15080536
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Hypertrophic cardiomyopathy showing no 123I-BMIPP myocardial accumulation with type I CD36 deficiency].
    Watanabe K; Miyajima S; Kusano Y; Tanabe N; Hirokawa Y
    Kaku Igaku; 1997 Jul; 34(7):481-6. PubMed ID: 9293711
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Class Ia antiarrhythmic drug cibenzoline: a new approach to the medical treatment of hypertrophic obstructive cardiomyopathy.
    Hamada M; Shigematsu Y; Ikeda S; Hara Y; Okayama H; Kodama K; Ochi T; Hiwada K
    Circulation; 1997 Sep; 96(5):1520-4. PubMed ID: 9315541
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Efficacy of cibenzoline for chest oppression and ventricular arrhythmia during effort and alcohol consumption in a patient with hypertrophic obstructive cardiomyopathy: a case report].
    Sasayama T; Horimoto M; Takeda T; Takenaka T; Inoue H; Igarashi K; Akino M; Kikuchi K
    J Cardiol; 2000 Jun; 35(6):445-50. PubMed ID: 10884982
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mid-ventricular hypertrophic obstructive cardiomyopathy presenting with acute myocardial infarction.
    Sato Y; Matsumoto N; Matsuo S; Yoda S; Kunimoto S; Saito S
    Tex Heart Inst J; 2007; 34(4):475-8. PubMed ID: 18172535
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Hypertrophic non-obstructive cardiomyopathy assessed by dipyridamole thallium single photon emission computed tomography: comparisons with hypertrophic cardiomyopathy with a dilated heart].
    Mori T; Suda K; Ohnishi M; Kanoh Y; Shiotani H; Yokota Y; Fujitani K; Fukuzaki H; Maeda K
    J Cardiol; 1987 Mar; 17(1):35-46. PubMed ID: 3501444
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Disopyramide as coadjuvant treatment in obstructive hypertrophic cardiomyopathy].
    Rodriguez-Gonzalez M; Pérez-Reviriego ÁA; Castellano-Martinez A; Cascales-Poyatos HM
    An Pediatr (Engl Ed); 2021 Apr; 94(4):253-256. PubMed ID: 32646796
    [No Abstract]   [Full Text] [Related]  

  • 52. Morphologic determinants of hemodynamic state after ventricular septal myotomy-myectomy in patients with obstructive hypertrophic cardiomyopathy: M mode and two-dimensional echocardiographic assessment.
    Spirito P; Maron BJ; Rosing DR
    Circulation; 1984 Dec; 70(6):984-95. PubMed ID: 6541978
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Ventricular arrhythmias in obstructive hypertrophic cardiomyopathy. Continuous electrocardiographic study].
    Bourmayan C; Nouhaud M; Fournier C; Bouajina A; Desnos M; Gay J; Gerbaux A
    Presse Med; 1983 Oct; 12(34):2089-92. PubMed ID: 6226033
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Hypertrophic cardiomyopathy with mid-ventricular obstruction complicated by apical aneurysm appearing as delayed contrast hyperenhancement on magnetic resonance imaging: two case reports].
    Teraoka K; Hirano M; Ogawa T; Sasame A; Yanagisawa H; Namatame Y; Shindo N; Takei Y; Sasaki K; Katsuyama H; Abe K; Yamashina A
    J Cardiol; 2003 Aug; 42(2):87-94. PubMed ID: 12964519
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A case of mid-apical obstructive hypertrophic cardiomyopathy treated with a transapical myectomy approach: a case report.
    Scudeler TL; Rezende PC; Oikawa FT; da Costa LM; Hueb AC; Hueb W
    J Med Case Rep; 2014 Nov; 8():364. PubMed ID: 25384531
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elderly patients with hypertrophic cardiomyopathy: a subset with distinctive left ventricular morphology and progressive clinical course late in life.
    Lewis JF; Maron BJ
    J Am Coll Cardiol; 1989 Jan; 13(1):36-45. PubMed ID: 2909578
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypertrophic cardiomyopathy with ventricular septal hypertrophy localized to the apical region of the left ventricle (apical hypertrophic cardiomyopathy).
    Maron BJ; Bonow RO; Seshagiri TN; Roberts WC; Epstein SE
    Am J Cardiol; 1982 Jun; 49(8):1838-48. PubMed ID: 6211078
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alcoholization of the interventricular septum (Sigwart procedure) for treatment of hypertrophic cardiomyopathy.
    Di Mario C; Musso P; Moses JJ; Tucci G; Reimers B; Colombo A
    G Ital Cardiol; 1998 Jan; 28(1):45-9; discussion 50-2. PubMed ID: 9493045
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systolic anterior motion of the posterior mitral leaflet: a previously unrecognized cause of dynamic subaortic obstruction in patients with hypertrophic cardiomyopathy.
    Maron BJ; Harding AM; Spirito P; Roberts WC; Waller BF
    Circulation; 1983 Aug; 68(2):282-93. PubMed ID: 6683131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Assessment of pathophysiology based on the left ventricular shape in five patients with midventricular obstructive hypertrophic cardiomyopathy].
    Aoki M; Uekita K; Obata H; Makiguchi N; Mitsuoka T; Kikuchi K
    J Cardiol; 2007 Jul; 50(1):29-38. PubMed ID: 17685027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.